The interplay between progressively developing insulin resistance and eventually failing compensatory pancreatic insulin hypersecretion is widely considered the hallmark of T2DM, but there are different interpretations (possibly corresponding to actual differences in pathophysiologic mechanisms between patient sub-populations) as to the causal chain leading to the eventual decompensation. Here, INS is linked to type 2 diabetes mellitus.